Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US Drug Pricing: What A Difference A Year Makes

Executive Summary

Drug makers were optimistic going into 2018 about the political climate and drug pricing environment, but the outlook is more tenuous heading into 2019. Now is the time when industry raises prices on mature, marketed drugs and it's unclear how those hikes may be tempered or what the backlash might be.

Advertisement

Related Content

J.P. Morgan Notebook Day 3: Biotech Feeling Government Shutdown, AstraZeneca, Denali, Allergan, Aptinyx, Sangamo
J.P. Morgan Notebook Day 3: Biotech Feeling Government Shutdown, AstraZeneca, Denali, Allergan, Aptinyx, Sangamo
DTC Ad Proposal: Biopharma, Advertisers Marshall Legal Arguments In Opposition
Retail Drug Spending In US Flat For 2017 Due Mainly To 'Non-Price' Factors
The Inevitable Is Coming: Price Increases, Starting With Pfizer
Rebate Reform: Big Changes Are Looming For The US Drug Market
Medicare's Foreign Price Bench-marking Will Only Hurt Bad Negotiators, HHS's Azar Argues
Industry Makes A Drug Price Transparency Push In DTC Ads, But Is It Too Little Too Late?
Pfizer Agrees To Roll Back Prices On 40 Drugs, Yielding To Pressure From Trump
'Immediate' Steps To Lower Drug Prices: The HHS Action Plan

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC124417

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel